c-Jun-N-terminal kinase dependent membrane targeting of CD95 in rat hepatic stellate cells

Cellular Physiology and Biochemistry

Volumn 12, Issue 4, 2002, Pages 179-186

  Cariers, Alexandra ^a   Reinehr, Roland ^a   Fischer, Richard ^a   Warskulat, Ulrich ^a   Häussinger, Dieter ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Apoptosis; c jun N terminal kinase; CD95 ligand; CD95 receptor; Hepatic stellate cells; Rat liver

Indexed keywords

8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; CASPASE 3; CASPASE 8; CYCLOHEXIMIDE; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL MEMBRANE; CONTROLLED STUDY; DEPHOSPHORYLATION; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME INHIBITION; FLUORESCENCE ANALYSIS; GENE EXPRESSION; LIVER CELL; MALE; MEMBRANE TRANSPORT; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIZATION; STELLATE CELL; WESTERN BLOTTING;

EID: 0036389445     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066277     Document Type: Article

References (23)

1. Pinzani M, Marra F, Carloni V: Signal transduction in hepatic stellate cells. Liver 1998;18:2-13.
2. Friedman SL: Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury. J Biol Chem 2000;275:2247-2250.
3. Gressner AM: The biology of liver fibrogenesis - an imbalance of proliferation, growth arrest and apoptosis of myofibroblasts. Cell Tissue Res 1998;292:447-452.
4. Gong W, Roth S, Lahme B, Beato M, Gressner AM: Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand. Hepatology 1998;28:492-502.
5. Fulda S, Meyer E, Debatin KM: Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Cancer Res 2000;60:3947-3956.
6. Graf D, Kurz AK, Fischer R, Reinehr R, Häussinger D: Tauroursodeoxycholate prevents taurolithocholic acid-3 sulfate induced apoptosis independent of PI 3-kinase and upstream of caspase 8 activation. Gastroenterology 2002, in press.
7. Sodeman T, Bronk SF, Roberts PJ, Miyoshi H, Gores GJ: Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am J Physiol Gastrointest Liver Physiol 2000;278:G992-G999.
8. Lee Y, Shacter E: Fas aggregation does not correlate with Fas-mediated apoptosis. J Immunol 2001;167:82-89.
9. Vlahos CS, Matter WF, Hui KY, Brown RF: A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY 294002). J Biol Chem 1994;269:5241-5248.
10. Fischer R, Schmitt M, Bode JG, Häussinger D: Expression of the peripheral-type benzodiazepine receptor and apoptosis induction in hepatic stellate cells. Gastroenterology 2001;120:1212-1226.
11. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997;91:231-241.
12. Chan TO, Rittenhouse SE, Tsichlis PN: Akt/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 1999;68:965-1014.
13. Guo YL, Baysal K, Kang B, Yang LJ, Williamson JR: Correlation between sustained cJun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J Biol Chem 1998;273:4027-4034.
14. Chen Y, Lai MZ: c-Jun NH2-terminal kinase activation leads to a FADD-dependent but CD95 ligand-independent cell death in Jurkat T cells. J Biol Chem 2001;276:8350-8357.
15. Leppa S, Bohmann D: Diverse functions of JNK and c-Jun in stress response and apoptosis. Oncogene 1999;18:6158-6162.
16. Reinehr RM, Kubitz R, Peters-Regehr T, Bode JG, Häussinger D: Activation of rat hepatic stellate cells in culture is associated with increased sensitivity to endothelin-1. Hepatology 1998;28:1566-1577.
17. Bode JG, Peters-Regehr T, Gressner AM, Häussinger D: De novo expression of glutamine synthetase during transformation of hepatic stellate cells into myofibroblast-like cell. Biochem J 1998;335:697-700.
18. Jacobson PB, Kuchera SL, Metz A, Schachtele C, Imre K, Schrier DJ: Anti-inflammatory properties of Gö 6850: a selectice inhibitor of protein kinase C. J Pharmacol Exp Ther 1995;275:995-1002.
19. Fatava MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM: Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998;273:18623-18632.
20. Manthey CL, Wang SW, Kinney SD, Yao Z: SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J Leukoc Biol 1998;64:409-417.
21. Gross A, McDonnell JM, Korsmeyer SJ: Bcl-2 family members and the mitochondria in apoptosis. Genes Devel 1999;13:1899-1911.
22. Guo YL, Kang B, Williamson JR: Inhibition of the expression of mitogen-activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J Biol Chem 1998;273:10362-10366.
23. Kharbanda S, Saxena S, Yoshidak K, Pandey P, Kaneki M, Wang Q, Cheng K, Chen YN, Campbell A, Sudha T, Yuan ZM, Narula J, Weichselbaum R, Nalin C, Kufe D: Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage. J Biol Chem 2000;275:322-327.